Detalhe da pesquisa
1.
Dopamine transporter (DAT) imaging in Parkinson's disease and related disorders.
J Neural Transm (Vienna)
; 129(5-6): 581-594, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34910248
2.
The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human.
Biochem J
; 475(11): 1861-1883, 2018 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29743203
3.
The onset of nonmotor symptoms in Parkinson's disease (the ONSET PD study).
Mov Disord
; 30(2): 229-37, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25449044
4.
Rare variants in LRRK1 and Parkinson's disease.
Neurogenetics
; 15(1): 49-57, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24241507
5.
A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease.
Am J Hum Genet
; 89(1): 168-75, 2011 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21763483
6.
The role of SCARB2 as susceptibility factor in Parkinson's disease.
Mov Disord
; 28(4): 538-40, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23408458
7.
Variants in eukaryotic translation initiation factor 4G1 in sporadic Parkinson's disease.
Neurogenetics
; 13(3): 281-5, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22707335
8.
Signal recognition particle (SRP) positive myositis in a patient with cryptogenic organizing pneumonia (COP).
Rheumatol Int
; 30(10): 1361-5, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19639324
9.
[Memantine for treatment of behavioural disturbances and psychotic symptoms in moderate to moderately severe Alzheimer dementia: a naturalistic study in outpatient services in Austria]. / Memantin in der Behandlung von Verhaltensauffälligkeiten und psychotischen Symptomen bei moderater bis mittelschwerer Alzheimer-Demenz: Eine naturalistische Studie im ambulanten Bereich in Osterreich.
Neuropsychiatr
; 24(2): 125-31, 2010.
Artigo
em Alemão
| MEDLINE | ID: mdl-20605008
10.
Role of LINGO1 polymorphisms in Parkinson's disease.
Mov Disord
; 24(16): 2404-7, 2009 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19908305
11.
Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis.
J Neurol
; 255(10): 1508-14, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18685917
12.
Long-term effects of STN DBS on mood: psychosocial profiles remain stable in a 3-year follow-up.
BMC Neurol
; 8: 43, 2008 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-19014430
13.
Serotonin transporter binding in Tourette Syndrome.
Neurosci Lett
; 385(2): 120-5, 2005 Sep 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-15936877
14.
Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson's disease (the VANTAGE study): a non-randomised, prospective, multicentre, open-label study.
Lancet Neurol
; 14(7): 693-701, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26027940
15.
Rare variants in ß-Amyloid precursor protein (APP) and Parkinson's disease.
Eur J Hum Genet
; 23(10): 1328-33, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25604855
16.
Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology.
World J Biol Psychiatry
; 3(3): 133-46, 2002 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12478878
17.
Recurrent vascular events in patients with ischemic stroke/TIA and atrial fibrillation in relation to secondary prevention at hospital discharge.
Wien Klin Wochenschr
; 116(24): 834-8, 2004 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-15690967
18.
Rare variants in PLXNA4 and Parkinson's disease.
PLoS One
; 8(11): e79145, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24244438
19.
Subthalamic nucleus deep brain stimulation reduces freezing of gait subtypes and patterns in Parkinson's disease.
Brain Stimul
; 11(6): 1404-1406, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30174201
20.
Fully automated 3D basal ganglia activity measurement in dopamine transporter scintigraphy (Spectalyzer).
Ann Nucl Med
; 24(4): 295-300, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20232177